In addition, immunohistochemical results from invasive breast biopsies from 1,162 patients demonstrated that PELP1 expression was an independent prognostic predictor of shorter breast cancer-specific survival and disease-free interval, and its expression can be used to assess positive clinical results of breast cancer in ESR1 positive patients (31). This evidence concerns the gene PELP1 and breast carcinoma.